KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Long-Term Investments (2016 - 2025)

Gilead Sciences' Long-Term Investments history spans 16 years, with the latest figure at $3.0 billion for Q4 2025.

  • For Q4 2025, Long-Term Investments changed N/A year-over-year to $3.0 billion; the TTM value through Dec 2025 reached $3.0 billion, changed N/A, while the annual FY2025 figure was $3.0 billion, N/A changed from the prior year.
  • Long-Term Investments reached $3.0 billion in Q4 2025 per GILD's latest filing, up from $2.0 billion in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $3.0 billion in Q4 2025 to a low of $579.0 million in Q1 2021.
  • Average Long-Term Investments over 4 years is $1.4 billion, with a median of $1.3 billion recorded in 2021.
  • The largest YoY upside for Long-Term Investments was 160.76% in 2021 against a maximum downside of 83.59% in 2021.
  • A 4-year view of Long-Term Investments shows it stood at $1.3 billion in 2021, then decreased by 4.89% to $1.2 billion in 2022, then decreased by 6.59% to $1.2 billion in 2023, then soared by 155.72% to $3.0 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Long-Term Investments are $3.0 billion (Q4 2025), $2.0 billion (Q3 2025), and $1.9 billion (Q2 2025).